Newsroom

Qosina Corp. and its beauty division, Qosmedix, are proud to announce they have been awarded a bronze medal for Corporate Social Responsibility from EcoVadis, the world's most trusted provider of business sustainability ratings.

Qosina is pleased to announce they now carry a sterile 3D-printed nasopharyngeal COVID-19 testing swab for nasal mucosa specimen collection.

ISO 80369-7, which specifies dimensions and requirements for the design and performance of small-bore connectors intended to be used in intravascular or hypodermic applications, is currently under revision.

Qosina is pleased to offer 3D-printed nasopharyngeal swabs, plus anterior nares swabs for nasal mucosa specimen collection during COVID-19 testing.

Qosina is pleased to announce they have teamed up with veteran medical adhesive manufacturer H.B. Fuller to offer a selection of off-the-shelf instant and UV-curable cyanoacrylate adhesive solutions for bonding medical device assemblies.

Qosina offers a wide selection of in-stock tubing for prototyping and large-scale production requirements.

Qosina is pleased to co-sponsor Medical Product Outsourcing’s upcoming webinar, “Pandemic Outsourcing: Best Practices and Lessons Learned” on Wednesday, May 27, at 2:00 ET.

In these uncertain times, Qosina understands it is imperative that its customers quickly adapt to the changing needs of the medical device industry.

Qosina carries a broad selection of in-stock, single-use bioprocessing components.

Qosina Corp President and CEO Scott Herskovitz today released a statement to customers regarding COVID-19 and the actions the company is taking to handle this unprecedented situation